The clinicopathological association between high CCR5 expression and deeper invasion supports the findings of promoted cell invasion and upregulated MMP2 mRNA expression in the three ESCC cell lines by rhCCL3 treatment. The gene discussed is MMP2; the disease is esophageal squamous cell carcinoma.